A recently published staffing model survey has brought new insights into oncology pharmacy operations across the country.

The Hematology/Oncology Pharmacy Association Practice Outcomes and Professional Benchmarking Committee (POPBC) Oncology Pharmacy Staffing Model Task Force developed a survey-based study in order to help provide an outline of oncology pharmacy staffing and operation practices. Distributed between September 2021 and January 2022, the survey collected baseline data and staffing metrics for oncology pharmacies - including facilities, inpatient and outpatient services, informatics/technology and more. The responses not only provided further insight into the unique oncology pharmacy operations and staffing models around the country, but also highlighted a need for staffing model benchmarking and metrics.

The full results are now published in the Journal of Oncology Pharmacy Practice.


Authors: Andrew Wechter, Anne M. McDonnell, Emily Zimdars, Leanne Sakamoto and Mark Hamm

Read the full article here

An image of Acute Myeloid Leukemia cells
HOPA News Late Breaking News

Late-Breaking HOPA News: The Evolving Landscape of NPM1-Mutated AML

Moh'd Mohanad A. Al-Dabet, PhD, AHI(AMT); Katia Al-Sawalha, BSc; and Olivia White, PharmD, BCOP, review revumenib and ziftomenib for NPM-1m disease and highlight key considerations when implementing these two therapies.

An image of a lung inside the body
HOPA News Late Breaking News

Late-Breaking HOPA News: Lurbinectedin and Atezolizumab for Extensive-Stage Small Cell Lung Cancer

Ming-Hei Tai, PharmD, BCOP, and Alexis Chapman, PharmD, BCOP, discuss the IMforte trial concerning lurbinectedin and atezolizumab in the treatment of extensive-stage small cell lung cancer.

Pharmacist with technology
HOPA News Late Breaking News

Late-Breaking HOPA News: AI Integration in Pharmacy

Aracely Sosa, PharmD; Katelyn Toeniskoetter, PharmD, BCOP; and Pearl Abraham, PharmD, BCPS, BCOP, dive into the basics and beyond of AI integration in pharmacy.